Ed Seguine, CEO of #ClinicalInk, talks about how hybrid trials, #BYOD ePRO, and DDC can provide a valuable solution during a healthcare crisis like #COVID19.

You can learn more about Ed Seguine and Clinical Ink here

Source:

Pin It on Pinterest